REFERENCES
1. Hui L, Bianchi DW. Prenatal pharmacotherapy for fetal anomalies: a 2011 update. Prenat Diagn 2011;31:735-43.
2. Ampola MG, Mahoney MJ, Nakamura E, Tanaka K. Prenatal therapy of a patient with vitamin-B12-responsive methylmalonic acidaemia.
N Engl J Med 1975;293:313-17.3. Wacker-Gussmann A, Strasburger JF, Cuneo BF, Wakai RT. Diagnosis and treatment of fetal arrhythmia. Am J Perinatol 2014;31:617-28.
4. Api O, Carvalho JS. Fetal dysrhythmias. Best Pract Res Clin Obstet Gynaecol 2008;22:31-48.
5. Jaeggi ET, Carvalho JS, De Groot E, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 2011;124:1747-54.
6. Srinivasan S, Strasburger J. Overview of fetal arrhythmias. Curr Opin Pediatr 2008;20:522-31.
7. Eliasson H, Sonesson SE, Sharland G, et al. Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 2011;124:1919-26.
8. Khalid JM, Oerton JM, Dezateux C, Hindmarsh PC, Kelnar CJ, Knowles RL. Incidence and clinical features of congenital adrenal hyperplasia in Great Britain. Arch Dis Child 2012;97:101-106.
9. David M, Forest MG. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984;105:799-803.
10. Lajic S, Nordenstrom A, Hirvikoski T Long term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency. Endocr Dev 2011;20:96-105.
11. Bertrand G, Drame M, Martageix C, Kaplan C. Prediction of the fetal status in non- invasive management of alloimmune thrombocytopenia. Blood 2011; 117:3209-13.
12. Zdravic D, Yougbare I, Vadasz B, et al. Fetal and neonatal alloimmune thrombocytopenia. Semin Fetal Neonatal Med 2016;21:19-27.
13. Spencer JA, Burrows RF.
Feto-maternal alloimune thrombocytopenia: a literature review and statistical analysis. Aust N Z J Obstet Gynaecol 2001;41:45-55.14. Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 2011;5:CD004226.
15. Donald I, MacVicar J, Brown TG. Investigation of abdominal masses by pulsed ultrasound. Lancet 1958;1:1188-95.
16. Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu HR, Kemp JR. The management of severe rhesus isoimmunisaton by fetoscopic intravascular transfusion. Am J Obstet Gynecol 1984;150:769-74.
17. Pretlove SJ, Fox CE, Khan KS, Kilby MD. Non-invasive methods of detecting fetal anaemia: a systematic review and meta-analysis. BJOG 2009;116:1558-67.
18. Van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetal anaemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 2005;192:171-77.
19. Mackie FL, Pretlove SJ, Martin WL, Donovan V, Kilby MD. Fetal intracardiac transfusions in hydropic fetuses with severe anaemia. Fetal Diagn Ther 2015;38:61-64.
20. Lindenburg IT, van Kamp IL, Oepkes D. Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 2014;36:263-71.
21. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tac hyarrhythmias: transplacental and direct treatment of the fetus— a report of 60 cases. Ultrasound Obstet Gynecol 1991;1:162-70.
22. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998;79:576-81.
23. Cabassa P, Fichera A, Prefumo F, et al. The use of radiofrequency in the treatment of twin reversed arterial perfusion sequence: a case series and review of the literature. Eur J Obstet Gynecol Reprod Biol 2013;166:127-32.
24. Wong AE, Sepulveda W. Acardiac anomaly: current issues in prenatal assessment and treatment. PrenatDiagn 2005;25:796-806.
25.
Swamy R, Embleton N, Hale J. Sacrococcygeal teratoma over two decades: birth prevalence, prenatal diagnosis and clinical outcomes. Prenat Diagn 2008;28:1048-51.26. Van Mieghem T, Al-Ibrahim A, Deprest J, et al. Minimally invasive therapy for fetal sacrococcygeal teratoma: case series and systematic review of the literature. Ultrasound Obstet Gynecol 2014;43:611-19.
27. Zanardini C, Papageorghiou A, Bhide A, Thilaganathan B. Giant placental chorioangioma: natural history and pregnancy outcome. Ultrasound Obstet Gynecol 2010;35:332-36.
28. Bebbington M. Selective reduction in multiple gestations. Best Pract Res Clin Obstet Gynaecol 2014;28:239-47.
29. Rustico MA, Baietti MG, Coviello D, Orlandi E, Nicolini U. Managing twins discordant for fetal anomaly. Prenat Diagn 2005;25:766-71.
30. Dias T, Ladd S, Mahsud-Dornan S, Bhide A, Papageorghiou AT, Thilaganathan B. Systematic labelling of twin pregnancies on ultrasound. Ultrasound Obstet Gynecol 2011;38:130-33.
31. Bhide A, Sairam S, Hollis B, Thilaganathan B. Comparison of feticide carried out by cordocentesis versus cardiac puncture. Ultrasound Obstet Gynecol 2002;20:230-232.
32. Eddleman KA, Stone JL, Lynch L, Berkowitz RL. Selective termination of anomalous fetuses in multifetal pregnancies: Two hundred cases at a single center. Am J Obstet Gynecol 2002;187:1168-72.
33. Clewell WH, Johnson ML, Meier PR, et al. A surgical approach to the treatment of fetal hydrocephalus. N Engl J Med 1982;306:1320-25.
34. Manning FA, Harrison MR, Rodeck C. Catheter shunts for fetal hydronephrosis and hydrocephalus. N Engl J Med 1986;315:336-40.
35. Freedman AL, Johnson MP, Gonzalez R. Fetal therapy for obstructive uropathy: past, present, future? Pediatr Nephrol 2000;14:167-76.
36. Clark TJ, Martin WL, Divakaran TG, Whittle MJ, Kilby MD, Khan KS. Prenatal bladder drainage in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet Gynecol 2003;102,:367-82.
37. Morris RK, Malin GL, Quinlan-Jones E, et al. The Percutaneous shunting in Lower Urinary Tract Obstruction (PLUTO) study and randomised controlled trial: evaluation of the effectiveness, costeffectiveness and acceptability of percutaneous vesicoamniotic shunting for lower urinary tract obstruction. Health Technol Assess 2013;17:1-232.
38. Longaker MT, Laberge JM, Dansereau J, et al. Primary fetal hydrothorax: natural history and management. J Pediatr Surg 1989;24:573-76.
39. Aubard Y, Derouineau I, Aubard V, Chalifour V, Preux PM. Primary fetal hydrothorax: a literature review and proposed antenatal clinical strategy. Fetal Diagn Ther 1998;13:325-33.
40. O'Brien B, Kesby G, Ogle R, Rieger I, Hyett JA. Treatment ofprimary fetal hydrothorax with OK-432 (Picibanil): outcome in 14 fetuses and a review of the literature. Fetal Diagn Ther 2015;37:259-66.
41. Mandelbaum B, Evans TN. Life in the amniotic fluid. Am J Obstet Gynecol 1969;104:365-77.
42. Lewi L, Jani J, Blickstein I, et al. The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study. Am J Obstet Gynecol 2008;199:514.e1-8.
43. Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol 1999;8:550-55.
44. Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twintransfusion syndrome. NEngl JMed 2004;351:136-14.
45. Slaghekke F, Lopriore E, Lewi L, et al. Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to- twin transfusion syndrome: an open-label randomised controlled trial. Lancet 2014;383:2144-51.
46. van Klink JM, Koopman HM, van Zwet EW, et al. Improvement in neurodevelopmental outcome in survivors of twin-twin transfusion syndrome treated with laser surgery. Am J Obstet Gynecol 2014;210:540.e1-7.
47. Lewi L, Van Schoubroeck D, Gratacos E, Witters I, Timmerman D, Deprest J.
Monochorionic diamniotic twins: complications and management options. Curr Opin Obstet Gynecol 2003;15:177-94.48. Bebbington M. Selective reduction in multiple gestations. Best Pract Res Clin Obstet Gynaecol 2014;28:239-47.
49. Rossi AC, DAddario V. Umbilical cord occlusion for selective feticide in complicated monochorionic twins: a systematic review of literature. Am J Obstet Gynecol 2009;200:123-29.
50. Deprest J, Gratacos E, Nicolaides KH; FETO Task Group. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results. Ultrasound Obstet Gynecol 2004;24:121-26.
51. Deprest J, Jani J, Gratacos E, et al. Fetal intervention for congenital diaphragmatic hernia: the European experience. Semin Perinatol 2005;29:94-103.
52. Harrison MR, Adzick NS, Bullard KM, et al. Correction of CDH in utero. VII. A prospective trial. J Pediatr Surg 1997;32:1637-42.
53. Harrison MR, Keller RL, Hawgood SB, et al. A randomized trial of fetal endoscopic tracheal occlusion for severe fetal congenital diaphragmatic hernia. N Engl J Med 2003;349: 1916-24.
54. Jani JC, Nicolaides KH, Gratacos E, et al. Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol 2009;34:304-10.
55. Deprest JA, Flake AW, Gratacos E, et al. The making of fetal surgery. Prenat Diagn 2010;30:653-67.
56. Bruner JP, Tulipan N, Paschall RL, et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA 1999;282:1819-25.
57. Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011;364:993-1004.
58. Araujo Junior E, Eggink AJ, van den Dobbelsteen J, Martins WP, Oepkes D. Procedure-related complications of open versus fetoscopic fetal surgery for treatment of spina bifida: systematic review and meta-analysis in the new era of intrauterine myelomeningocoele repair. Ultrasound Obstet Gynecol 2016;2:151-60.
59. Mychaliska GB, Bealer JF, Graf JL, Rosen MA, Adzick NS, Harrison MR. Operating on placental support: the ex utero intrapartum treatment procedure. J Pediatr Surg 1997; 32:227-30.
60. Bouchard S, Johnson MP, Flake AW, et al. The EXIT procedure: experience and outcome in 31 cases. J Pediatr Surg 2002;37: 418-26.